GE5-10334-00343
3 vaccinations
4 coded responses
25 check-ins
1 free-text entry
3 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 488 / MI
- Registered
- 2022-07-17
- Relationship
- Child or adolescent in my care
- Guardian
- 4U5-26675-45049
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-12
Dose 1 — Moderna
-
2022-07-17
Registered in v-safe
-
2022-07-17
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-07-18
- 2022-07-19
- 2022-07-26
- 2022-08-02
-
2022-08-09
Dose 2 — Moderna
- 2022-08-09
- 2022-08-16
- 2022-08-23
- 2022-08-30
- 2022-09-06
- 2022-09-13
- 2022-09-20
-
2022-11-08
Survey response — 3 months, dose 2, under 3MedDRA: Gait inability, Pain in extremity — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: His foot is too sore to walk on and we aren't sure why. Taking him to the doctor today or tomorrow.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-08
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-09
-
2023-01-27
Dose 3 — Moderna
- 2023-01-29
- 2023-01-30
- 2023-01-31
- 2023-02-01
-
2023-02-02
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Erythema — Feeling: Poor · Fever · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-02
Report sent to call center — days 1–6 daily, dose 3, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-02-03
Survey response — day 7, dose 3, under 3MedDRA: Hand-foot-and-mouth disease, Skin ulcer, Stomatitis — Feeling: Poor · Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-02-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-02-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-02-12
Survey response — day 14, dose 3, under 3MedDRA: Drug eruption — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-12
Report sent to call center — day 14, dose 3, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-02-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-02-17
- 2023-02-24
- 2023-03-03
- 2023-03-10
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-12 | Moderna | No |
| 2 | 2022-08-09 | Moderna | No |
| 3 | 2023-01-27 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-08 | Successful 2023-02-03 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-02-02 | Successful 2023-02-03 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-02-12 | Successful 2023-02-13 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: His foot is too sore to walk on and we aren't sure why. Taking him to the doctor today or tomorrow.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Drug eruption | · | · | ✓ |
| SD | Gait inability | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SRO | Erythema | · | · | ✓ |
| SRO | Hand-foot-and-mouth disease | · | · | ✓ |
| SRO | Skin ulcer | · | · | ✓ |
| SRO | Stomatitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release